MEPDF 股息： MediPal Holdings Corporation 收益洞察

Q: MediPal Holdings Corporation 的关键财务报表是什么？

根据最新的财务报表（Form-10K），MediPal Holdings Corporation 的总资产为 $1,824,984，净利润为 $40,279

Q: MEPDF 的关键财务比率是什么？

MediPal Holdings Corporation 的流动比率是 1.51，净利 margin 为 1.09，每股销售为 $17,609.08。

Q: MediPal Holdings Corporation 的收入按细分市场或地理位置如何划分？

MediPal Holdings Corporation 最大收入来源是 Medical Drugs，在最近的收益报告中收入为 2,366,717,000,000。就地区而言， Japan 是 MediPal Holdings Corporation 的主要市场，收入为 3,671,328,000,000。

Q: MediPal Holdings Corporation 是否盈利？

是的，根据最新的财务报表，MediPal Holdings Corporation 的净利润为 $40,279

Q: MediPal Holdings Corporation 有负债吗？

是的，MediPal Holdings Corporation 的负债为 1,205,418

Q: MediPal Holdings Corporation 的流通股有多少？

MediPal Holdings Corporation 的总流通股为 207.95

主页

股票

MEPDF

MEPDF 财务

MediPal Holdings Corporation

$16.5

截至今日：Jan 22, 14:27:22 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$16.5

开盘价

$16.25

当日区间

$16.25 - $16.5

52周范围

$13.24 - $17.57

交易量

300

平均成交量

每股收益（TTM）

1.25

股息收益率

市值

$3.3B

什么是 MEDIPAL HOLDINGS CORP？

Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 13,061 full-time employees. The firm operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The firm also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.

功能特性

交易策略

资源

市场

收入

资产负债表

现金流量

年度

季度性

MEPDF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
营收	3,744,218	3,671,328	3,558,732	3,360,008	3,290,921	3,211,125
营收同比增长 (YoY)	4%	3%	6%	2%	2%	-1%
营收成本	3,484,621	3,415,569	3,312,077	3,135,703	3,073,476	2,996,912
毛利润	259,597	255,759	246,655	224,305	217,445	214,213
销售、一般及管理费用	192,562	185,216	184,686	163,040	159,379	162,802
研发	--	1,418	991	103	108	106
营业费用	206,067	200,150	199,325	175,333	171,821	175,637
其他非经营性收入 (费用)	10,729	10,845	11,448	9,959	10,246	9,158
税前利润	76,769	76,734	74,741	70,061	57,284	49,237
所得税费用	25,323	25,203	22,973	21,738	18,087	15,621
净利润	40,642	40,279	41,474	38,806	29,423	23,926
净利润增长	-12%	-3%	7%	32%	23%	-37%
稀释后流通股数	206.04	208.49	211.78	216.34	223.12	223.06
股份同比变动 (YoY)	-1%	-2%	-2%	-3%	0%	-3%
每股收益 (摊薄)	197.24	193.19	195.83	179.37	131.86	107.26
每股收益增长率	-11%	-1%	9%	36%	23%	-35%
自由现金流	34,134	48,128	48,192	2,642	42,340	18,780
每股自由现金流	--	--	--	--	--	--
毛利率	6.93%	6.96%	6.93%	6.67%	6.6%	6.67%
营业利润率	1.42%	1.51%	1.32%	1.45%	1.38%	1.2%
净利率	1.08%	1.09%	1.16%	1.15%	0.89%	0.74%
自由现金流利润率	0.91%	1.31%	1.35%	0.07%	1.28%	0.58%
EBITDA	72,003	74,026	65,312	63,620	59,962	53,368
EBITDA 利润率	1.92%	2.01%	1.83%	1.89%	1.82%	1.66%
EBITDA 中的折旧与摊销	18,473	18,417	17,982	14,648	14,338	14,792
EBIT	53,530	55,609	47,330	48,972	45,624	38,576
EBIT 利润率	1.42%	1.51%	1.32%	1.45%	1.38%	1.2%
有效税率	32.98%	32.84%	30.73%	31.02%	31.57%	31.72%

Follow-Up Questions

MediPal Holdings Corporation 的关键财务报表是什么？



MEPDF 的关键财务比率是什么？



MediPal Holdings Corporation 的收入按细分市场或地理位置如何划分？



MediPal Holdings Corporation 是否盈利？



MediPal Holdings Corporation 有负债吗？



MediPal Holdings Corporation 的流通股有多少？



MediPal Holdings Corporation（MEPDF）价格

MEPDF 股价走势图